500 related articles for article (PubMed ID: 27170747)
1. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
2. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
3. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
4. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.
Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadière B; van der Werf S; Autran B; Carcelain G;
Am J Respir Crit Care Med; 2014 May; 189(10):1240-9. PubMed ID: 24646009
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
[TBL] [Abstract][Full Text] [Related]
6. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
7. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
8. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.
Verma N; Dimitrova M; Carter DM; Crevar CJ; Ross TM; Golding H; Khurana S
J Virol; 2012 May; 86(10):5515-22. PubMed ID: 22379097
[TBL] [Abstract][Full Text] [Related]
10. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
[TBL] [Abstract][Full Text] [Related]
11. Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.
Liu X; Liu Y; Zhang Y; Chen Z; Tang Z; Xu Q; Wang Y; Zhao P; Qi Z
PLoS One; 2013; 8(3):e58810. PubMed ID: 23527030
[TBL] [Abstract][Full Text] [Related]
12. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.
Wei CJ; Yassine HM; McTamney PM; Gall JG; Whittle JR; Boyington JC; Nabel GJ
Sci Transl Med; 2012 Aug; 4(147):147ra114. PubMed ID: 22896678
[TBL] [Abstract][Full Text] [Related]
13. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
[TBL] [Abstract][Full Text] [Related]
14. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.
Park JK; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
mBio; 2018 Jan; 9(1):. PubMed ID: 29362240
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl].
Klimova RR; Masalova OV; Burtseva EI; Chichev EV; Lesnova EI; Oskerko TA; Mukasheva EA; Rudneva IA; Lvov DK; Kushch AA
Vopr Virusol; 2011; 56(3):15-20. PubMed ID: 21786621
[TBL] [Abstract][Full Text] [Related]
17. Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection.
Fox A; Mai le Q; Thanh le T; Wolbers M; Le Khanh Hang N; Thai PQ; Thi Thu Yen N; Minh Hoa le N; Bryant JE; Duong TN; Thoang DD; Barr IG; Wertheim H; Farrar J; Hien NT; Horby P
J Infect; 2015 Feb; 70(2):187-96. PubMed ID: 25224643
[TBL] [Abstract][Full Text] [Related]
18. Novel correlates of protection against pandemic H1N1 influenza A virus infection.
Ng S; Nachbagauer R; Balmaseda A; Stadlbauer D; Ojeda S; Patel M; Rajabhathor A; Lopez R; Guglia AF; Sanchez N; Amanat F; Gresh L; Kuan G; Krammer F; Gordon A
Nat Med; 2019 Jun; 25(6):962-967. PubMed ID: 31160818
[TBL] [Abstract][Full Text] [Related]
19. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
[TBL] [Abstract][Full Text] [Related]
20. Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses.
Shembekar N; Mallajosyula VV; Malik A; Saini A; Varadarajan R; Gupta SK
Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):191-8. PubMed ID: 27463230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
